CLARITY F2F Meeting 10 October 2024

The first CLARITY consortium meeting (Utrecht, the Netherlands, Oct 9-10 2024) is a wrap! 🎉 

Partners from Germany, Spain, Germany Estonia and the Netherlands, as well as the international RSV Patient Network came to meet and discuss research in CLARITY (Causative Link between respirAtory syncytial viRus and chronic respiratory diseases: Identifying Targets for therapY). We started the meeting with a poignant story from an RSV infant patient who is now 5 years old, explained wonderfully by his mother Brenda van Voorthuizen. CLARITY consortium consists of Marianne Boes (UMC Utrecht, coordinator 🇳🇱), Marleen Van Ampting, PhD, (UMC Utrecht, manager 🇳🇱), with Louis Bont (UMC Utrecht, 🇳🇱), Pascal Falter-Braun (Helmholtz Munich 🇩🇪 ), Claudia Falter (Helmholtz Munich 🇩🇪 ), Patrick Aloy (IRB Barcelona 🇪🇸 ), Inmaculada Casas (Instituto de Salud Carlos III 🇪🇸 ), @Cristina Calvo 🇪🇸 , María de la Montaña Iglesias Caballero (Servicio madrileño de salud (SERMAS)  🇪🇸 ), Erik Abner (University of Tartu 🇪🇪 ), Daan Pieren, Sonja Rittchen, Leyla Kragten-Tabatabaie, Lies Kriek and Isabelle Phijffer (ReSViNET | Respiratory Syncytial Virus (RSV) Foundation 🌍 ). UMC Utrecht leads the international consortium that will run for five years, funded by a HORIZON HLTH 2023 grant from the European Commission of € 7.1 million. European Health and Digital Executive Agency (HaDEA), Horizon Europe CLARITY project EU